Massive Blood Transfusion Complications
Disclaimer.The materials on this page are intended for informational and educational purposes. No individuals should use the information, resources or tools contained herein to self-diagnosis or self-treat any health-related condition. The content of the website is not meant to be a substitute for advice provided by a doctor or other qualified health care professional. The company will not be held responsible for any negative consequences arising from the use of information posted on this site.
Continued research into resuscitation strategies and evolving technology and blood product storage has allowed for patient to undergo very large volume transfusions, even to the point of replacing a patient’s blood volume several times over. As massive transfusions have become more common, more studies have been performed delineating the exact patient population that would benefit, start- and stop-points of transfusions, complications and avoidance of the same.
Therefore, the blood banks should be encouraged to remove impediments to rapid issuing of blood component. In addition, the medical/surgical department should discuss the feasibility of the fixed blood component ratio and the consequences of its use. Finally, the hospital blood bank should realize that the fixed blood component ratio measures would improve the access to blood components, reduce mortality, and decrease unnecessary blood component utilization.
Hendrickson JE, Hillyer CD. Noninfectious serious hazards of transfusion. Anesth Analg. 2009;108:759–69. \
Vamvakas EC, Blajchman MA. Universal WBC reduction: The case for and against. Transfusion. 2001;41:691–712.
Hebert PC, Fergusson D, Blajchman MA, Wells GA, Kmetic A, Coyle D, Heddle N, Germain M, Goldman M, Toye B, Schweitzer I, vanWalraven C, Devine D, Sher GD. Clinical outcomes following institution of the canadian universal leukoreduction program for red blood cell transfusions. JAMA. 2003
Wang SE, Lara PN, Jr, Pee-Ow A. Acetaminophen and diphenhydramine as predemication for platelet transfusions: A prospective randomized double-blind placebo-controlled trial. Am J Hematol. 2002
Sanders RP, Maddirala SD, Geiger TL, Pounds S, Sandlund JT, Ribeiro RC, Pui CH, Howard SC. Premedication with acetominophen or diphenhydramine for transfusion with leukoreduced blood products in children. Br J Haematol. 2005